Lyell Immunopharma

Forecast & Rating9 analysts currently cover Lyell Immunopharma, with about 77.8% giving a positive rating — meaning they expect the stock to rise. The average price target is $37.88, about 143.9% upside from the current price of $15.53. Price targets range from $12.00 to $49.00 — a wide spread, showing clear disagreement over just how much Lyell Immunopharma can rise. Historically, about 8.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Lyell Immunopharma closely still see room for the stock to rise. Data as of Aug 15, 2026; for reference only and not investment advice.